• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

    44.80 -0.66 (-1.45%)
    Streaming Delayed Price Updated: 11:29 AM EST, Nov 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Hims & Hers Health, Inc. Class A Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    46 47 Next >
    Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
    Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday. 
    Via Benzinga
    Earnings Scheduled For November 3, 2025
     
    Via Benzinga
    Stock Market Today: S&P 500, Dow Jones Futures Rise After Stellar October Gains— Micron Tech, Palantir, Hims & Hers In Focus
    U.S. stock futures advanced on Monday after Friday’s positive moves. Futures of major benchmark indices were higher. 
    Via Benzinga
    Topics Stocks
    Hims & Hers Health Brings Menopause, Perimenopause Treatments On Its Platform
    Via Stocktwits
    Hims & Hers Health (HIMS) Q3 Earnings: What To Expect
    Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings this Monday afternoon. Here’s what you need to know. 
    Via StockStory
    Why Hims & Hers Health (HIMS) Stock Is Trading Up Today
    Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.4% in the afternoon session after JPMorgan Chase & Co. disclosed in a regulatory filing that it had taken a significant passive... 
    Via StockStory
    10 Health Care Stocks Whale Activity In Today's Session
     
    Via Benzinga
    1 Profitable Stock on Our Watchlist and 2 We Find Risky
    While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
    Via StockStory
    Topics Retirement
    Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
    Hims & Hers stock is falling well off its 52-week highs, as bears lean on the CEO's scheduled sale that just took place, though it might be a mistake. 
    Via MarketBeat
    1 Mid-Cap Stock Worth Your Attention and 2 We Avoid
    Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
    Via StockStory
    Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks
    Here's a look at the most heavily shorted stocks in the market as investors look for the next Beyond Meat. 
    Via Benzinga
    Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges
    The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic... 
    Via MarketMinute
    Topics Economy Stocks World Trade
    This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
     
    Via Benzinga
    Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
    Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.9% in the morning session after investors looked past a recent insider stock sale and focused on the company's strong growth... 
    Via StockStory
    Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks
    Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
    Via Benzinga
    Topics World Trade
    Trump's Weight-Loss Drug Push May Put These ETFs On A Diet
    Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure. 
    Via Benzinga
    Topics ETFs Government
    Why Is Hims & Hers Health Stock Down 12% Today?
    According to a SEC filing on Thursday, CEO Andrew Dudum sold 175,661 shares of the company for an aggregate value of about $11 million. 
    Via Stocktwits
    Topics Regulatory Compliance
    Why Hims & Hers Health Shares Are Sliding Friday
    Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease. 
    Via Benzinga
    Topics Government
    Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'
    Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss drugs are going to go down in price. 
    Via Benzinga
    Topics Government
    Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
    Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.8% in the afternoon session after a Bank of America analyst maintained a Sell rating on the stock, citing multiple concerns about the... 
    Via StockStory
    Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem
    Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on healthcare. 
    Via Benzinga
    Hims & Hers Stock Jumps 9% After Huge Announcement
    New products are coming to the Hers platform. 
    Via The Motley Fool
    Hims & Hers Stock Notches Best Day In 3 Months After BofA’s Bullish Call On Menopause Launch: Retail Hails Year’s ‘Best Swing Trade Stock’
    The rally followed BofA Securities’ announcement that the new menopause and perimenopause service represents a multi-billion-dollar market opportunity for HIMS, supporting revenue diversification. 
    Via Stocktwits
    Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today
    Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31. 
    Via Benzinga
    Topics Stocks
    Why Hims & Hers Stock Blasted 16% Higher on Wednesday
    Investors liked what they heard about the company's latest expansion of its business. 
    Via The Motley Fool
    Investors Are Buying Hims & Hers Health Stock Following Wednesday's Platform Expansion Announcement
    Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Wednesday following the company's launch of a new menopause and perimenopause care specialty on its Hers platform. 
    Via Benzinga
    Why Are Hims & Hers Health (HIMS) Shares Soaring Today
    Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 5.7% in the afternoon session after the company announced the launch of perimenopause and menopause treatment options on its platform.... 
    Via StockStory
    Topics Artificial Intelligence
    IBD 50's Hims & Hers Surges After Announcing A Menopause Care Launch
    Shares are nearing a buy point out of a cup-with-handle base. 
    Via Investor's Business Daily
    Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
    From Hims & Hers
    Via Business Wire
    Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?
    Investors looking at the healthcare industry have two excellent choices with UnitedHealth and Hims & Hers. 
    Via The Motley Fool
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    46 47 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.